VALVECURE, LLC


Overview

Cardiovascular device technology, specifically addressing a therapy to cure functional mitral and tricuspidregurgitation. Our technologies have successfully undergone pre-clinical testing, and we are seeking funding to fulfill clinical testing, "First-In-Man". The main platform technology, BarrelEye is patent and trademark pending. Additional IP in the structural heart space.

Video Pitch


Management Team

Edward Hlozek